Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 22, 2005
The psychosocial impact of cervical cancer among affected women and their partnersJ M de Groot, K Mah, A Fyles, et al.Gynecologic Oncology|December 6, 2000
Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?R Goshen, W Chu, L Elit, et al.Gynecologic Oncology|September 1, 1989
Concurrent radiation and chemotherapy in vulvar carcinomaG Thomas, A Dembo, A DePetrillo, et al.Gynecologic Oncology|September 1, 1990
Concurrent chemoradiation in advanced cervical cancerG Thomas, A Dembo, A Fyles, et al.European Journal of Gynaecological Oncology|July 4, 2002
Familial and hormonal risk factors for papillary serous uterine cancerL Elit, T Pal, R Goshen, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapyH Steed, L Manchul, B Rosen, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|February 17, 2018
Prognostic Significance of Human Papilloma Virus and p16 Expression in Patients with Vulvar Squamous Cell Carcinoma who Received RadiotherapyM L Yap, G Allo, J Cuartero, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|August 21, 2016
Building a New Model of Care for Rapid Breast Radiotherapy Treatment Planning: Evaluation of the Advanced Practice Radiation Therapist in Cavity DelineationG Lee, R Dinniwell, F F Liu, et al.International Journal of Radiation Oncology, Biology, Physics|October 19, 1999
Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy: results of a prospective treatment protocolR Wong, M Milosevic, J Sturgeon, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 12, 2004
The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers--a study of the National Cancer Institute of Canada Clinical Trials GroupB B Y Ma, A Oza, E Eisenhauer, et al.Pageof 4